Valuation: Incyte Corporation

Market Cap 2.35TCr 2.06TCr 1.92TCr 1.76TCr 3.31TCr 2,26400Cr 3.36TCr 23TCr 8.91TCr 1,11300Cr 8.83TCr 8.63TCr 3,84800Cr P/E 2026 *
66.9x
P/E 2027 * 15.8x
Enterprise Value 1.95TCr 1.71TCr 1.59TCr 1.46TCr 2.75TCr 1,87800Cr 2.79TCr 19TCr 7.39TCr 92TCr 7.32TCr 7.16TCr 3,19200Cr EV / Sales 2026 *
3.4x
EV / Sales 2027 * 2.83x
Free-Float
98.11%
Yield 2026 *
-
Yield 2027 * -
1 day+0.84%
1 week+0.36%
Current month+3.80%
1 month+3.45%
3 months+24.32%
6 months+14.71%
Current year+19.14%
1 week 114.5
Extreme 114.505
119.13
1 month 110.56
Extreme 110.56
119.6
Current year 89.25
Extreme 89.25
119.6
1 year 69.7
Extreme 69.695
119.6
3 years 50.27
Extreme 50.27
119.6
5 years 50.27
Extreme 50.27
119.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
16/07/26 Free

EVP, Human Resources

39,018 0.0195%
16/07/26 Free

Principal Accounting Officer

6,913 0.0035%
16/07/26 Free

EVP & Chief Scientific Officer

46,244 0.0231%
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%+0.36%+67.62%+87.37% 2.35TCr
+0.63%-3.06%+16.50%-10.25% 6.67TCr
-0.45%+2.90%+36.93%+202.87% 5.33TCr
+10.08%+51.80%+51.80%+51.80% 4.81TCr
+1.90%-5.07%-56.99%-56.52% 3.83TCr
+0.78%-1.84%+53.73%-23.77% 2.99TCr
-5.17%-12.54%+58.33%-55.18% 2.15TCr
+1.31%+3.24%+81.47%+159.24% 1.65TCr
+0.39%-1.08%+62.53%+123.85% 1.64TCr
-0.22%+4.78%+139.02%+216.27% 1.24TCr
Average +1.01%-0.17%+51.09%+69.57% 3.26TCr
Weighted average by Cap. +1.64%+0.19%+36.50%+55.00%

Financials

2026 *2027 *
Net sales 573.12Cr 503.37Cr 468.12Cr 429.56Cr 807.12Cr 55TCr 819.56Cr 5.56TCr 2.17TCr 27TCr 2.15TCr 2.11TCr 94TCr 620.62Cr 545.09Cr 506.92Cr 465.16Cr 874.01Cr 60TCr 887.48Cr 6.02TCr 2.35TCr 29TCr 2.33TCr 2.28TCr 1,01600Cr
Net income 36Cr 32Cr 30Cr 27Cr 51Cr 3.5TCr 52Cr 352.02Cr 137.53Cr 1.72TCr 136.25Cr 133.31Cr 5.94TCr 151.36Cr 132.94Cr 123.63Cr 113.45Cr 213.16Cr 15TCr 216.45Cr 1.47TCr 573.58Cr 7.17TCr 568.22Cr 555.97Cr 25TCr
Net Debt -400.7Cr -351.93Cr -327.29Cr -300.33Cr -564.3Cr -39TCr -573Cr -3.89TCr -1.52TCr -19TCr -1.5TCr -1.47TCr -66TCr -592.68Cr -520.55Cr -484.1Cr -444.23Cr -834.67Cr -57TCr -847.54Cr -5.75TCr -2.25TCr -28TCr -2.22TCr -2.18TCr -97TCr
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
24/26/24 $117.67 +0.84% 12,07,106
23/26/23 $116.69 +0.78% 9,56,259
22/26/22 $115.79 -1.36% 9,98,480
21/26/21 $117.39 +1.50% 19,06,845
20/26/20 $115.65 -1.36% 12,57,145
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
117.67USD
Average target price
114.55USD
Spread / Average Target
-2.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock